AstraZeneca (AstraZeneca) Insider Ownership : 0.16 % (As of Apr. 26, 2024)

View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, AstraZeneca's insider ownership is 0.16%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, AstraZeneca's Institutional Ownership is 12.57%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, AstraZeneca's Float Percentage Of Total Shares Outstanding is 0.00%.

AstraZeneca Insider Ownership Historical Data

The historical data trend for AstraZeneca's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Insider Ownership Chart

AstraZeneca Historical Data

The historical data trend for AstraZeneca can be seen below:

	2023-06-30	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31
Insider Ownership	0.14	0.14	0.14	0.14	0.14	0.15	0.15	0.15	0.15	0.16

AstraZeneca Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

AstraZeneca (AstraZeneca) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.